Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Thổ Nhĩ Kỳ tăng cường UAV giám sát biển Aegean

Thổ Nhĩ Kỳ tăng cường UAV giám sát biển Aegean

Thế giới
(Baothanhhoa.vn) - Ngày 5/9, Thổ Nhĩ Kỳ đã gia tăng hoạt động sử dụng máy bay không người lái (UAV) Bayraktar để giám sát trên biển Aegean, trong bối cảnh căng thẳng giữa Ankara và Athens liên quan các hoạt động quân sự và quyền kiểm soát trên vùng biển này tiếp tục...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh